Tuesday, November 19, 2024
LBNN
  • Business
  • Markets
  • Politics
  • Crypto
  • Finance
  • Energy
  • Technology
  • Taxes
  • Creator Economy
  • Wealth Management
  • Documentaries
No Result
View All Result
LBNN

Under-the-skin Keytruda comparable to infused version in Phase 3 study, Merck says

Simon Osuji by Simon Osuji
November 19, 2024
in Technology
0
Under-the-skin Keytruda comparable to infused version in Phase 3 study, Merck says
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Merck plans to discuss the data with regulators as it lags rivals Roche and Bristol Myers in bringing forward a subcutaneous form of its cancer drug.

Related posts

Merck acquires cancer drug startup; Elevidys ex-US sales rise

Astellas application rejected by FDA; Cytokinetics strikes licensing deal with Bayer

November 19, 2024
Reps committee seeks tax break, vocational grants to empower youths in renewable energy – EnviroNews

Reps committee seeks tax break, vocational grants to empower youths in renewable energy – EnviroNews

November 19, 2024

Source link

Previous Post

Cape Town may pump as much sewage into the sea as it likes

 Next Post

25 Best Early Black Friday Deals of 2024 to Shop Right Now
Next Post
25 Best Early Black Friday Deals of 2024 to Shop Right Now

25 Best Early Black Friday Deals of 2024 to Shop Right Now

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

RECOMMENDED NEWS

Pakistan Air Force to Employ Chinese FC-31 Gyrfalcon Jets ‘In Near Future’

Pakistan Air Force to Employ Chinese FC-31 Gyrfalcon Jets ‘In Near Future’

11 months ago
Russian mobile labs to expand to Ethiopia and Congo

Russian mobile labs to expand to Ethiopia and Congo

2 months ago
5 Things to Look for When Hiring a Patent Portfolio Manager

5 Things to Look for When Hiring a Patent Portfolio Manager

1 year ago
Sponsored: Jubilant’s Precision Medicines Offer Safety, Therapeutic Advantages in Cancer, Immunology

Sponsored: Jubilant’s Precision Medicines Offer Safety, Therapeutic Advantages in Cancer, Immunology

1 year ago

POPULAR NEWS

  • When Will SHIB Reach $1? Here’s What ChatGPT Says

    When Will SHIB Reach $1? Here’s What ChatGPT Says

    0 shares
    Share 0 Tweet 0

  • Matthew Slater, son of Jackson State great, happy to see HBCUs back at the forefront

    0 shares
    Share 0 Tweet 0

  • Dolly Varden Focuses on Adding Ounces the Remainder of 2023

    0 shares
    Share 0 Tweet 0

  • US Dollar Might Fall To 96-97 Range in March 2024

    0 shares
    Share 0 Tweet 0

  • Mass Casualty At Concerts: Vaccinated Crowds ‘Die Suddenly”

    0 shares
    Share 0 Tweet 0
  • Privacy Policy
  • Contact

© 2023 LBNN - All rights reserved.

No Result
View All Result
  • Home
  • Business
  • Politics
  • Markets
  • Crypto
  • Economics
    • Manufacturing
    • Real Estate
    • Infrastructure
  • Finance
  • Energy
  • Creator Economy
  • Wealth Management
  • Taxes
  • Telecoms
  • Military & Defense
  • Careers
  • Technology
  • Artificial Intelligence
  • Investigative journalism
  • Art & Culture
  • Documentaries
  • Quizzes
    • Enneagram quiz
  • Newsletters
    • LBNN Newsletter
    • Divergent Capitalist

© 2023 LBNN - All rights reserved.